What is Novavax's gross profit?

Novavax (NVAX) reported gross profit of $108.82M in Q1 2026.

How has Novavax's gross profit changed year-over-year?

Novavax's gross profit decreased by 83.3% year-over-year, from $652.54M to $108.82M.

What is the long-term trend for Novavax's gross profit?

Over 4 years (2021 to 2025), Novavax's gross profit has grown at a -2.2% compound annual growth rate (CAGR), from $1.15B to $1.05B.

What does gross profit mean?

Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Novavax NVAX Gross Profit

Gross Profit at other companies

Merck & Co.MRK

$12.09B-0.2%

ALN

Alnylam PharmaceuticalsALNY

$959.66M+83.1%

Gilead SciencesGILD

$5.52B+7.6%

Nektar TherapeuticsNKTR

$21.81M+2.9%

ModernaMRNA

——

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Revenue$139.5M-79.1%

Operating income-$15.4M-103%

Net income-$9.5M-102%

EPS (diluted)-$0.06-102%

Balance sheet

See full

Cash & equivalents$228.4M-13.3%

Total debt$295.1M+404%

Total equity-$144.8M-91.4%

Total assets$1.0B-19.3%

Cash flow

See full

Operating cash flow-$32.4M+82.5%

CapEx$1.3M-20.4%

Free cash flow-$33.7M+82.0%

Valuation

See full

Market cap$1.46B+28.6%

Enterprise value$1.53B+68.6%

P/S2.5×+1.5×

Profitability

See full

Gross margin85%-2.5pp

Operating margin-13.1%-45.9pp

Net margin-14.7%-52.9pp

FCF margin-58.9%-61.4pp

Returns & leverage

See full

Return on equity-238.6%—

Debt / equity1.5×—

Current ratio2.5×+0.4×

Where this comes from

Calculated from Novavax’s reported figures.

$139.5Mtotal revenue−$30.7Mtotal cost of revenue=$108.82M

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novavax's gross profit?: Novavax (NVAX) reported gross profit of $108.82M in Q1 2026.
How has Novavax's gross profit changed year-over-year?: Novavax's gross profit decreased by 83.3% year-over-year, from $652.54M to $108.82M.
What is the long-term trend for Novavax's gross profit?: Over 4 years (2021 to 2025), Novavax's gross profit has grown at a -2.2% compound annual growth rate (CAGR), from $1.15B to $1.05B.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.